Assessing Cost Hamiltonian Reliability in Quantum Protein Structure Prediction

Technical Summary: Assessing Cost Hamiltonian Reliability in Quantum Protein Structure Prediction

Problem Statement
In variational quantum algorithms (such as VQE, QAOA) and quantum annealing, the cost Hamiltonian defines the optimization landscape. However, in application-driven domains like Protein Structure Prediction (PSP), this Hamiltonian is often a simplified proxy for the true task-level objective. A fundamental validation problem arises: even if a quantum optimizer efficiently identifies low-energy states, these states may not correspond to high-quality structural solutions if the encoded Hamiltonian is not sufficiently aligned with the target metric (structural accuracy).

Current quantum formulations for PSP typically reduce the problem to a coarse-grained lattice model (specifically a tetrahedral lattice) and encode contact-based interaction energies into a cost Hamiltonian. While this enables compatibility with near-term quantum hardware, it creates a gap between the quantity being optimized (contact energy) and the desired outcome (structural accuracy measured by Root Mean Square Deviation, or RMSD). Previous works have focused on scalable implementations and algorithmic convergence but have not rigorously assessed whether the cost function itself is relevant to the problem before the quantum optimization step.

Methodology
The authors propose a methodology to evaluate the reliability of the cost Hamiltonian independently of the quantum algorithm used. The study utilizes a dataset of 12,446 peptides (including 4,866 unique sequences) ranging from 6 to 600 amino acids, sourced from the Protein Data Bank (PDB).

The workflow involves the following steps:

1. Solution Space Definition: PSP instances are encoded as self-avoiding walks on a tetrahedral lattice. A solution is represented as a list of turns ($t$) that determine the coordinates of $C_\alpha$ atoms.
2. Cost Function Calculation: The study employs a contact-energy cost function. This function sums interaction energies between amino acid pairs based on their Euclidean distance and sequence separation. It considers multiple "interaction shells" (orders of interaction) defined by distance thresholds ($d_{max}$) and sequence distance constraints ($k_{min}$).
3. Error Metric: The structural accuracy is measured by the RMSD between the predicted $C_\alpha$ coordinates and the experimentally determined ground truth structures.
4. Correlation Analysis:
   • For peptides with length $\le 15$, all feasible solutions are enumerated.
   • For peptides with length $> 15$, 10,000 feasible solutions are sampled using the Pivot algorithm.
   • For each peptide, the authors calculate the Spearman rank correlation coefficient ($\rho$) between the cost values and the RMSD values of the solutions.
   • Key metrics include the average RMSD, minimum RMSD, and the RMSD of the solution with the minimum cost.

Key Contributions and Results
The investigation yields three primary findings regarding the alignment between the cost Hamiltonian and structural accuracy:

1. Poor Correlation for Small Peptides: For small peptides, the energy landscape of the standard contact-energy cost Hamiltonian is not sufficiently correlated with the actual structural error (RMSD). Consequently, minimizing this cost function does not reliably yield structurally accurate predictions.
2. Scalability of Assessment: The relevance of the cost function can be estimated for large protein instances (where full enumeration is impossible) through Monte Carlo sampling. The study demonstrates that the Spearman correlation can be accurately estimated with 10,000 samples (yielding a 95% confidence interval amplitude of approximately 0.05).
3. Impact of Interaction Shells: The correlation between the cost function and the error increases for larger problem instances and, crucially, when more interaction shells (higher-order interaction terms) are considered.

Significance and Claims
The paper argues that the reliability of a cost Hamiltonian must be evaluated independently of the quantum optimization scheme (e.g., VQE, QAOA) used to solve it. The authors claim that for the specific PSP formulation studied:

• The standard cost function is not suitable for small peptides because it fails to capture the problem's structural nuances.
• There is a central trade-off in quantum algorithm design for biomolecular optimization: simpler cost Hamiltonians are easier to encode and require fewer quantum resources but provide poor approximations of the structural objective. Conversely, richer Hamiltonians (incorporating higher-order interactions) better reflect the underlying problem and improve correlation but introduce denser interaction graphs, higher-order dependencies, and more complex circuits.

The work concludes that quantifying this trade-off is essential for identifying formulations that are both structurally meaningful and realistic for near-term quantum hardware. The methodology presented allows researchers to validate objective functions for problem instances too large to run on current hardware, serving as a low-cost validation step to prioritize Hamiltonian formulations before committing quantum resources.